TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER

TTHealthWatch discusses genetic testing for couples planning pregnancy, use of two medications post-heart attack, genome-wide association models for cardiovascular disease risk, and two strategies to reduce lipoprotein(a). Polygenic risk scores show limited individual precision, and nationwide genetic carrier screening in Australia identified 1.9% of couples at risk for genetic conditions, with 77% opting for reproductive interventions.

At the STRIPE Annual Meeting & Consensus Workshop, ASP announced the inaugural STRIPE Double Helix Awards, recognizing excellence in pharmacogenomics through collaboration and outstanding achievement. Recipients include Kristine Ashcraft, Cynthia Bens, Burns C. Blaxall, Philip Empey, Jose Estabil, Bernard Esquivel, Christine Formea, Blaine Groat, Daniel Hertz, Carrie Hoefer, Geoff Hollett, J. Shawn Jones, Raymond Lorenz, Ryan Nelson, Micheal Pacanowski, Jai N. Patel, Victoria Pratt, Bronwyn Ramey, Sharmeen Roy, Robert Schuck, April Schultz, Jeffrey A. Shaman, Sharon Shriver, Patrick Silva, D. Max Smith, Annette Taylor, Wrenda Teeple, McKenna Tennant, Kelly E. Caudle, Emily Cicali, Andrea Gaedigk, Houda Houchad, Pamala Jacobson, Teri E. Klein, Akinyemi Oni-Orisan, Natasha Petry, Bani Tamraz, Kristin Wiisanen, and Michelle Whirl-Carrillo. Organizations honored include the Golden Helix Foundation, Department of Veteran Affairs - National Pharmacogenomics Program, and Advocates for Universal DPD/DPYD Testing.

CoherentMI reports the Clinical Trial Software Market valued at US$ 0.9 Billion in 2024, projected to reach US$ 2.3 Billion by 2031, growing at a CAGR of 14.3%. Factors include increased R&D investments, COVID-19 accelerating digital health solutions, and the rise of cloud-based and AI technologies in clinical trials.

The Clinical Trial Software Market is projected to grow from US$ 0.9 Bn in 2024 to US$ 2.3 Bn by 2031, at a CAGR of 14.3%. Key drivers include increased digitalization, rising R&D investments, and the adoption of telehealth solutions, particularly during the COVID-19 pandemic.